Skip to main content

Advertisement

Advances in in vitro modeling of the blood-brain barrier and neurovascular unit

© John J. Jamieson et al., 2019

In this thematic issue, Fluids and Barriers of the CNS aims to bring together papers related to in vitro modeling of the blood-brain barrier and the neurovascular unit (NVU). In recent years, major advances have been made in the field including the use of brain endothelial cells derived from human induced pluripotent stem cells, NVU models composed of multiple cell types, and the development of novel 3D models, including the use of microchips. Such advances are increasing our understanding of barrier function and intercellular crosstalk in health and disease, identification of therapeutic targets, and methods for high-throughput screenings of drugs for treatment of neurological diseases. 

We are welcoming submissions that address advances in in vitro modeling, including original research, reviews and commentaries (e.g. on future directions). Papers can address the utility and limitations of such models in relation to BBB physiology, pathophysiology and pharmacology.

This collection of articles has not been sponsored and articles have undergone the journal’s standard peer-review process.

Submission deadline: December 1st, 2019.

To submit your work, please use the online submission system and select the name of the series when completing the additional information section of the submission form.

Examples of relevant work recently published by Fluids and Barriers of the CNS include:

  1. Content type: Research

    Blood–brain barrier dysfunction is associated with many late-stage neurodegenerative diseases. An emerging question is whether the mutations associated with neurodegenerative diseases can independently lead to...

    Authors: Moriah E. Katt, Lakyn N. Mayo, Shannon E. Ellis, Vasiliki Mahairaki, Jeffrey D. Rothstein, Linzhao Cheng and Peter C. Searson

    Citation: Fluids and Barriers of the CNS 2019 16:20

    Published on:

  2. Content type: Research

    Immune cell trafficking into the CNS is considered to contribute to pathogenesis in MS and its animal model, EAE. Disruption of the blood–brain barrier (BBB) is a hallmark of these pathologies and a potential ...

    Authors: Shujun Ge, Xi Jiang, Debayon Paul, Li Song, Xiaofang Wang and Joel S. Pachter

    Citation: Fluids and Barriers of the CNS 2019 16:18

    Published on:

  3. Content type: Research

    Pericytes of the blood–brain barrier (BBB) are embedded within basement membrane between brain microvascular endothelial cells (BMECs) and astrocyte end-feet. Despite the direct cell–cell contact observed in v...

    Authors: John J. Jamieson, Raleigh M. Linville, Yuan Yuan Ding, Sharon Gerecht and Peter C. Searson

    Citation: Fluids and Barriers of the CNS 2019 16:15

    Published on:

  4. Content type: Research

    Brain endothelial cell-based in vitro models are among the most versatile tools in blood–brain barrier research for testing drug penetration to the central nervous system. Transcytosis of large pharmaceuticals...

    Authors: Andrea E. Toth, Simone S. E. Nielsen, Weronika Tomaka, N. Joan Abbott and Morten S. Nielsen

    Citation: Fluids and Barriers of the CNS 2019 16:14

    Published on: